STOCK TITAN

Korro Bio (KRRO) CEO sells 5,802 shares of stock to cover taxes

(Neutral)
(Negative)
Form Type
4

Rhea-AI Filing Summary

Korro Bio, Inc. reports that President and CEO Ram Aiyar sold 5,802 shares of common stock on August 4, 2026 at a weighted-average price of $10.844 per share in mandatory sales solely to cover tax withholding on vested RSUs under its 2023 Stock Option and Incentive Plan. Following these transactions, he holds 69,046 shares directly, including 20,000 unvested RSUs scheduled to vest on February 1, 2027 subject to a continuous Service Relationship, and 4,613 shares are held indirectly through The Ram Aiyar Irrevocable Trust.

Positive

  • None.

Negative

  • None.
Insider Aiyar Ram
Role President and CEO
Sold 5,802 shs ($63K)
Type Security Shares Price Value
Sale Common Stock F1, F2, F3 5,802 $10.844 $63K
holding Common Stock F4 -- -- --
Holdings After Transaction: Common Stock — 69,046 shares (Direct); Common Stock — 4,613 shares (Indirect, Shares are held by The Ram Aiyar Irrevocable Trust.)
Footnotes (4)
  1. F1. Represents the mandatory sale of shares of common stock solely to satisfy tax withholding obligations incurred upon vesting and settlement of a restricted stock unit (RSU) granted under the Issuer's 2023 Stock Option and Incentive Plan (the 2023 Plan).
  2. F2. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $10.57 to $11.055, inclusive. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request.
  3. F3. Includes 20,000 shares of common stock issuable upon settlement of a RSU granted under the 2023 Plan that will vest on February 1, 2027 subject to the reporting person maintaining a continuous Service Relationship (as defined in the 2023 Plan) through such date.
  4. F4. Shares held by The Ram Aiyar Irrevocable Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
Shares sold 5,802 shares Common stock sold on 2026-08-04 to satisfy tax withholding
Average sale price $10.844 per share Weighted-average price for the 5,802 sold shares
Sale price range $10.57–$11.055 per share Range of prices across multiple sale transactions
Direct holdings after sale 69,046 shares Common stock held directly following the reported transaction
Unvested RSUs 20,000 shares Shares issuable upon RSU settlement vesting on February 1, 2027
Indirect trust holdings 4,613 shares Shares held by The Ram Aiyar Irrevocable Trust
restricted stock unit financial
"upon vesting and settlement of a restricted stock unit (RSU) granted under the 2023 Plan"
A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.
2023 Stock Option and Incentive Plan financial
"RSU granted under the Issuer's 2023 Stock Option and Incentive Plan (the 2023 Plan)"
weighted-average price financial
"The price reported in Column 4 is a weighted-average price."
Weighted-average price is the average of multiple prices where each price is counted according to its size or importance—larger trades carry more weight than smaller ones, like averaging course grades by credit hours. It matters to investors because it gives a more realistic picture of the true price paid or received, helping assess trade execution, compare performance, calculate cost basis, and value positions more accurately than a simple average.
pecuniary interest financial
"disclaims beneficial ownership of these securities except to the extent of his pecuniary interest"
Irrevocable Trust financial
"Shares held by The Ram Aiyar Irrevocable Trust, for which the Reporting Person serves as trustee."
An irrevocable trust is a legal arrangement where an owner transfers assets into a separate entity managed by a trustee and gives up the power to modify or reclaim those assets. For investors it matters because putting stock or other holdings into such a trust can change who controls and benefits from the assets, affect taxes and creditor protection, and influence how easy it is to sell or value those holdings—like placing valuables in a locked safe overseen by someone else.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What insider transaction did Korro Bio (KRRO) CEO Ram Aiyar report?

Ram Aiyar reported selling 5,802 Korro Bio common shares on August 4, 2026 at a weighted-average price of $10.844 per share. The sale was a mandatory transaction to cover tax withholding tied to vested RSUs under the company’s 2023 Stock Option and Incentive Plan.

Why did the Korro Bio (KRRO) CEO sell 5,802 shares?

The 5,802 shares were sold solely to satisfy tax withholding obligations from vesting and settlement of restricted stock units granted under Korro Bio’s 2023 Stock Option and Incentive Plan, according to the filing’s footnote describing the transaction as a mandatory sale.

What are Ram Aiyar’s Korro Bio (KRRO) holdings after this Form 4 sale?

After the reported sale, Ram Aiyar holds 69,046 Korro Bio shares directly, including 20,000 shares issuable upon settlement of unvested RSUs. He is also trustee for 4,613 additional shares held by The Ram Aiyar Irrevocable Trust, with beneficial ownership disclaimed except for pecuniary interest.

At what prices were the 5,802 Korro Bio (KRRO) shares sold?

The filing reports a $10.844 weighted-average sale price for the 5,802 shares. A footnote explains the shares were sold in multiple transactions at prices ranging from $10.57 to $11.055 per share, with detailed breakdowns available on request.

What RSU award does the Korro Bio (KRRO) CEO still have outstanding?

Ram Aiyar’s direct holdings include 20,000 shares of Korro Bio common stock issuable upon settlement of an RSU. This RSU grant will vest on February 1, 2027, provided he maintains a continuous Service Relationship through that vesting date.
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Aiyar Ram

(Last)(First)(Middle)
C/O KORRO BIO, INC.
60 FIRST STREET, 2ND FLOOR, SUITE 250

(Street)
CAMBRIDGE MASSACHUSETTS 02141

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Korro Bio, Inc. [ KRRO ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
XDirector10% Owner
XOfficer (give title below)Other (specify below)
President and CEO
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
08/04/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Common Stock08/04/2026S(1)5,802D$10.844(2)69,046(3)D
Common Stock4,613IShares are held by The Ram Aiyar Irrevocable Trust.(4)
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. Represents the mandatory sale of shares of common stock solely to satisfy tax withholding obligations incurred upon vesting and settlement of a restricted stock unit (RSU) granted under the Issuer's 2023 Stock Option and Incentive Plan (the 2023 Plan).
2. The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions at prices ranging from $10.57 to $11.055, inclusive. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission upon request.
3. Includes 20,000 shares of common stock issuable upon settlement of a RSU granted under the 2023 Plan that will vest on February 1, 2027 subject to the reporting person maintaining a continuous Service Relationship (as defined in the 2023 Plan) through such date.
4. Shares held by The Ram Aiyar Irrevocable Trust, for which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein, and the inclusion of these shares in this report shall not be deemed an admission of beneficial ownership of all of the reported shares for purposes of Section 16 or for any other purpose.
/s/ Jeffrey Cerio, Attorney-in-fact08/05/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)